Shift toward minimally invasive methods to uplift drug-eluting balloons market
Coronary artery disease is a usual kind of heart disease. It arises as a result of stiffening and contracting of arteries that provide blood to the muscle of the heart due to the accumulation of cholesterol and other constituents on their inner walls. This leads to inadequate oxygen and blood flow to the heart muscle via the arteries, obstructing its standard functioning. This can result in heart attack and chest pain. The key reason for a heart attack is the impulsive interruption of blood supply to the heart, which perpetually harms the organ. It also weakens the heart muscle and contributes to arrhythmias and heart failure.
Drug-eluting balloons (DEBs) play a significant part in the coronary artery disease treatment. DEB is a developing device that enhances clinical results in coronary artery diseases. Thus, it is a feasible treatment alternative for the restriction of coronary restenosis and consequent revascularization via stent technologies. In recent years, DEBs have received attention with rising alertness about its high efficacy and safety than the existing available treatment alternatives. Thus, the growth of the drug-eluting balloons market is expected to uplift in the coming period.
The major factors fueling the growth of the market include the rising geriatric population, growing obesity, and rising occurrence of coronary artery diseases, diabetes, and peripheral artery diseases. Further, advanced applications of DEBs and elevated support by the government in the form of research &funding have driven the market growth. Additionally, the increasing need for effectual therapies that will assist in decreasing the difficulties linked to drug eluting stents will boost the demand for DEBs.
Moreover, open peripheral surgeries and open heart surgeries include several difficulties and at times can be life-threatening. A clear inclination is shown by surgeons toward minimally invasive methods as they are extremely precise, are less painful, make for quicker recovery times, cause fewer post-surgery infections, decrease the hospital stays, offers more control on bleeding, and has nominal problems.
Furthermore, technological advancement in the field of catheterization, for instance, robot-assisted catheterization for percutaneous coronary intervention, have allowed advanced digital imaging to enhance the recognition and intervention associated with cardiac diseases. This has fortified the increase cath lab numbers, and thus the demand for DEBs.